Genome-wide monocytic mRNA expression in polytrauma patients for identification of clinical outcome

Shock

Volumn 24, Issue 1, 2005, Pages 11-19

  Biberthaler, Peter ^a   Bogner, Viktoria ^a   Baker, Henry V ^b   López, M Cecilia ^b   Neth, Peter ^a   Kanz, Karl Georg ^a   Mutschler, Wolf ^a   Jochum, Marianne ^a   Moldawer, Lyle L ^b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Gene expression; Microarray; MODS; Multiple injury; SIRS

Indexed keywords

MESSENGER RNA; STRESS ACTIVATED PROTEIN KINASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DNA MICROARRAY; ENZYME ACTIVATION; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE PROBE; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; MONOCYTE; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; PERIPHERAL CIRCULATION; SIGNAL TRANSDUCTION; SURVIVAL;

ADULT; AGED; CLUSTER ANALYSIS; FEMALE; GENOME, HUMAN; GENOMICS; HUMANS; MALE; MIDDLE AGED; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 21744445422     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000163394.93467.77     Document Type: Article

References (35)

1. Mannick JA, Rodrick ML, Lederer JA: The immunologic response to injury. J Am Coll Surg 193:237-244, 2001.
2. Baue AE, Durham R, Faist E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 10:79-89, 1998.
3. Lederer JA, Rodrick ML, Mannick JA: The effects of injury on the adaptive immune response. Shock 11:153-159, 1999.
4. Angele MK, Faist E: Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit Care 6:298-305, 2002.
5. Cioffi WG, Burleson DG, Pruitt BAJ: Leukocyte responses to injury. Arch Surg 128:1260-1267, 1993.
6. Oberholzer A, Oberholzer C, Moldawer LL: Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16:83-96, 2001.
7. Chung TP, Laramie JM, Province M, Cobb JP: Functional genomics of critical illness and injury. Crit Care Med 30(1 Suppl):S51-S57, 2002.
8. Committee on Injury Scaling: Abbreviated Injury Scale 1990 Revision. Des Plaines, IL: Association of the Advancement of Automovement Medicine, 2002.
9. Biberthaler P, Neth P, Bach B, Mayer V, Mussack T, Mutschler W, Jochum M: Initial RNA expression in human monocytes after multiple injury: a screening pilot study on potentially trauma-sensitive factors by using the microarray-technique. Eur J Med Res 8:473-484, 2003.
10. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH: Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci USA 87:1663-1667, 1990.
11. Li C, Hung WW: Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2(8): 31-36, 2001.
12. Simon R, Radmacher MD, Dobbin K, McShane LM: Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 95:14-18, 2003.
13. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868, 1998.
14. Lefering R, Goris RJ, van Nieuwenhoven EJ, Neugebauer E: Revision of the multiple organ failure score. Langenbecks Arch Surg 387:14-20, 2002.
15. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121, 2001.
16. Li C, Wong WH: Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98:31-36, 2001.
17. Botha AJ, Moore FA, Moore EE, Sauaia A, Banerjee A, Peterson VM: Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma 39:411-417, 1995.
18. Zahler S, Kowalski C, Brosig A, Kupatt C, Becker BF, Gerlach E: The function of neutrophils isolated by a magnetic antibody cell separation technique is not altered in comparison to a density gradient centrifugation method. J Immunol Methods 200:173-179, 1997.
19. Cotter MJ, Norman KE, Hellewell PG, Ridger VC: A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. Am J Pathol 159:473-481, 2001.
20. Guha M, Mackman N: LPS induction of gene expression in human monocytes. Cell Signal 13:85-94, 2001.
21. Feezor RJ, Baker HV, Xiao W, Lee WA, Huber TS, Mindrinos M, Kim RA, Ruiz-Taylor L, Moldawer LL, Davis RW, Seeger JM: Genomic and proteomic determinants of outcome in patients undergoing thoracoabdominal aortic aneurysm repair. J Immunol 172:7103-7109, 2004.
22. Ben-Dor A, Bruhn L, Friedman N, Nachman I, Schummer M, Yakhini Z: Tissue classification with gene expression profiles. J Comput Biol 7:559-583, 2000.
23. Lee Y, Lee CK: Classification of multiple cancer types by multicategory support vector machines using gene expression data. Bioinformatics 19:1132-1139, 2003.
24. Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, Haferlach T: Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia 18:63-71, 2004.
25. Faist E, Schinkel C, Zimmer S: Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 20:454-459, 1996.
26. Eferl R, Wagner EF: AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3:859-868, 2003.
27. Shaulian E, Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-E136, 2002.
28. Rangatia J, Vangala RK, Treiber N, Zhang P, Radomska H, Tenen DG, Hiddemann W, Behre G: Down regulation of c-Jun expression by transcription factor C/EBPalpha is critical for granulocytic lineage commitment. Mol Cell Biol 22:8681-8694, 2002.
29. Murono S, Yoshizaki T, Sato H, Takeshita H, Furukawa M, Pagano JS: Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res 60:2555-2561, 2000.
30. Vasanwala FH, Kusam S, Toney LM, Dent AL: Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J Immunol 169:1922-1929, 2002.
31. Li A, Dubey S, Varney ML, Dave BJ, Singh RK: IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369-3376, 2003.
32. Lossos IS, Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R: Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 98:945-951, 2001.
33. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM: BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13:199-212, 2000.
34. Roach DM, Fitridge RA, Laws PE, Millard SH, Varelias A, Cowled PA: Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg 23:260-269, 2002.
35. Jarrar D, Song GY, Kuebler JF, Rue LW, Bland KI, Chaudry IH: The effect of inhibition of a major cell signaling pathway following trauma hemorrhage on hepatic injury and interleukin 6 levels. Arch Surg 139:896-901, 2004.